Tumor types in this population of breast cancer patients included 25 (63%) triple negative, 12 (30%) hormone receptor positive (ER or PR ≥1%), and three (7%) HER2 overexpressed (see Table 1). This evidence concerns the gene ERBB2 and neoplasm.